81 FR 34361 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 104 (May 31, 2016)

Page Range		34361-34361
FR Document		2016-12647

Federal Register, Volume 81 Issue 104 (Tuesday, May 31, 2016)

[Federal Register Volume 81, Number 104 (Tuesday, May 31, 2016)]
[Notices]
[Page 34361]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-12647]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended
    (5 U.S.C. App), notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Synthesis and Distribution of Opioid and Related 
Peptides (7795).
    Date: June 28, 2016.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.nih.gov.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Non-Clinical ADME Studies (8931).
    Date: July 13, 2016.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Lyle Furr, Scientific Review Officer, Office of 
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS, 
Room 4227, MSC 9550, 6001 Executive Boulevard, Bethesda, MD 20892-
9550, (301) 435-1439, lf33c.nih.gov.

(Catalogue of Federal Domestic Assistance Program No.: 93.279, Drug 
Abuse and Addiction Research Programs, National Institutes of 
Health, HHS).

    Dated: May 24, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-12647 Filed 5-27-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 104 / Tuesday, May 31, 2016 / Notices 34361

ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average time
Type of Number of Total annual
responses per per response
respondent respondents burden hour
respondent ( in hours)

NIH grantees and others with hESC lines ....................................................... 50 3 17 2,550

Total .......................................................................................................... 50 150 ........................ 2,550

Dated: May 24, 2016. Boulevard, Rockville, MD 20852 (Telephone Name of Committee: Interdisciplinary
Lawrence A. Tabak, Conference Call). Molecular Sciences and Training Integrated
Contact Person: Lyle Furr, Scientific Review Group; Enabling Bioanalytical and
Deputy Director, National Institutes of Health.
Review Officer, Office of Extramural Affairs, Imaging Technologies Study Section.
[FR Doc. 2016–12726 Filed 5–27–16; 8:45 am] National Institute on Drug Abuse, NIH, Date: June 23–24, 2016.
BILLING CODE 4140–01–P DHHS, Room 4227, MSC 9550, 6001 Time: 8:00 a.m. to 6:00 p.m.
Executive Boulevard, Bethesda, MD 20892– Agenda: To review and evaluate grant
9550, (301) 435–1439, lf33c.nih.gov. applications.
DEPARTMENT OF HEALTH AND (Catalogue of Federal Domestic Assistance Place: Hotel Kabuki, 1625 Post Street, San
HUMAN SERVICES Program No.: 93.279, Drug Abuse and Francisco, CA 94115.
Addiction Research Programs, National Contact Person: Kenneth Ryan, Ph.D.,
National Institutes of Health Institutes of Health, HHS). Scientific Review Officer, Center for
Dated: May 24, 2016. Scientific Review, National Institutes of
National Institute on Drug Abuse; Natasha M. Copeland,
Health, 6701 Rockledge Drive, Room 3218,
Notice of Closed Meeting MSC 7717, Bethesda, MD 20892, 301–435–
Program Analyst, Office of Federal Advisory 0229, kenneth.ryan@nih.hhs.gov.
Pursuant to section 10(d) of the Committee Policy.
Name of Committee: Oncology 2—
Federal Advisory Committee Act, as [FR Doc. 2016–12647 Filed 5–27–16; 8:45 am] Translational Clinical Integrated Review
amended BILLING CODE 4140–01–P Group;Cancer Immunopathology and
(5 U.S.C. App), notice is hereby given Immunotherapy Study Section.
Date: June 23–24, 2016.
of the following meeting. DEPARTMENT OF HEALTH AND Time: 8:00 a.m. to 1:00 p.m.
The meeting will be closed to the HUMAN SERVICES Agenda: To review and evaluate grant
public in accordance with the applications.
provisions set forth in sections National Institutes of Health Place: The Embassy Row Hotel, 2015
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Massachusetts Avenue NW., Washington, DC
as amended. The contract proposals and Center for Scientific Review; Notice of 20036.
the discussions could disclose Closed Meetings Contact Person: Denise R. Shaw, Ph.D.,
confidential trade secrets or commercial Scientific Review Officer, Center for
Pursuant to section 10(d) of the Scientific Review, National Institutes of
property such as patentable material, Federal Advisory Committee Act, as Health, 6701 Rockledge Drive, Room 6158,
and personal information concerning amended (5 U.S.C. App.), notice is MSC 7804, Bethesda, MD 20892, 301–435–
individuals associated with the contract hereby given of the following meetings. 0198, shawdeni@csr.nih.gov.
proposals, the disclosure of which The meetings will be closed to the Name of Committee: Center for Scientific
would constitute a clearly unwarranted public in accordance with the Review Special Emphasis Panel; Review of
invasion of personal privacy. provisions set forth in sections Neuroscience AREA Grant Applications.
Name of Committee: National Institute on 552b(c)(4) and 552b(c)(6), title 5 U.S.C., Date: June 23–24, 2016.
Drug Abuse Special Emphasis Panel; as amended. The grant applications and Time: 8:00 a.m. to 1:00 p.m.
Synthesis and Distribution of Opioid and the discussions could disclose Agenda: To review and evaluate grant
Related Peptides (7795). applications.
confidential trade secrets or commercial
Date: June 28, 2016. Place: DoubleTree by Hilton, 1515 Rhode
property such as patentable material, Island Avenue NW., Washington, DC 20005.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
and personal information concerning Contact Person: Richard D. Crosland,
proposals. individuals associated with the grant Ph.D., Scientific Review Officer, Center for
Place: National Institutes of Health, applications, the disclosure of which Scientific Review, National Institutes of
Neuroscience Center, 6001 Executive would constitute a clearly unwarranted Health, 6701 Rockledge Drive, Room 4190,
Boulevard, Rockville, MD 20852 (Telephone invasion of personal privacy. MSC 7850, Bethesda, MD 20892, 301–435–
Conference Call). 1220, crosland@nih.gov.
Name of Committee: Center for Scientific
Contact Person: Lyle Furr, Scientific Review Special Emphasis Panel; Member Name of Committee: Center for Scientific
Review Officer, Office of Extramural Affairs, Conflict: CVRS New Investigator. Review Special Emphasis Panel; Small
National Institute on Drug Abuse, NIH, Date: June 22, 2016. Business: Biomedical Sensing, Measurement
DHHS, Room 4227, MSC 9550, 6001 Time: 10:00 a.m. to 12:00 p.m. and Instrumentation.
Executive Boulevard, Bethesda, MD 20892– Agenda: To review and evaluate grant Date: June 24, 2016.
9550, (301) 435–1439, lf33c.nih.gov. applications. Time: 8:00 a.m. to 5:00 p.m.
Name of Committee: National Institute on Place: National Institutes of Health, 6701 Agenda: To review and evaluate grant
sradovich on DSK3TPTVN1PROD with NOTICES

Drug Abuse Special Emphasis Panel; Non- Rockledge Drive, Bethesda, MD 20892 applications.
Clinical ADME Studies (8931). (Telephone Conference Call). Place: Hilton Washington/Rockville, 1750
Date: July 13, 2016. Contact Person: Margaret Chandler, Ph.D., Rockville Pike, Rockville, MD 20852.
Time: 10:00 a.m. to 12:00 p.m. Scientific Review Officer, Center for Contact Person: Inna Gorshkova, Ph.D.,
Agenda: To review and evaluate contract Scientific Review, National Institutes of Scientific Review Officer, Center for
proposals. Health, 6701 Rockledge Drive, Room 4126, Scientific Review, National Institutes of
Place: National Institutes of Health, MSC 7814, Bethesda, MD 20892, (301435– Health, 6701 Rockledge Drive, Bethesda, MD
Neuroscience Center, 6001 Executive 1743, margaret.chandler@nih.gov. 20892, 301–435–1784, gorshkoi@csr.nih.gov.

VerDate Sep<11>2014 20:07 May 27, 2016 Jkt 238001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\31MYN1.SGM 31MYN1

Document Created: 2016-05-28 03:57:34
Document Modified: 2016-05-28 03:57:34

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 28, 2016.
FR Citation		81 FR 34361

81 FR 34361 - National Institute on Drug Abuse; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 104 (May 31, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health